<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02180893</url>
  </required_header>
  <id_info>
    <org_study_id>S12-02774</org_study_id>
    <nct_id>NCT02180893</nct_id>
  </id_info>
  <brief_title>The Use of Paravertebral Block for Cardiac Surgery</brief_title>
  <official_title>Study of Paravertebral Block for Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>New York University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>New York University School of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pain after robotic cardiac surgery is a known problem and is often difficult to manage.
      Paravertebral nerve blocks are a proven method of pain relief following thoracotomy. A
      paravertebral block has been shown to provide good pain relief with minimal side effects,
      however, paravertebral blocks for robotic surgery have not been well studied. Currently the
      investigators routinely perform PVB on this patient population (of 50 MV robotic cases done
      between January and October 2012, 36 received paravertebral blocks with no adverse events
      noted). The investigators believe this should be studied further and that paravertebral
      blocks will reduce the amount of additional pain medication patients require in the first 24
      hours after surgery, decrease intubation time and improve PACU and hospital discharge times.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pain after robotic cardiac surgery is a known problem and is often difficult to manage.
      Paravertebral nerve blocks are a proven method of pain relief following thoracotomy. A
      paravertebral block has been shown to provide good pain relief with minimal side effects,
      however, paravertebral blocks for robotic surgery have not been well studied. Currently we
      routinely perform PVB on this patient population (of 50 MV robotic cases done between January
      and October 2012, 36 received paravertebral blocks with no adverse events noted). We believe
      this should be studied further and that paravertebral blocks will reduce the amount of
      additional pain medication patients require in the first 24 hours after surgery, decrease
      intubation time and improve PACU and hospital discharge times.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Actual">April 2014</completion_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative Fentanyl</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analog Scale (VAS) Pain Scores</measure>
    <time_frame>24 hours</time_frame>
    <description>Possible scores range from 0-10, with 0 being no pain and 10 being highest level of pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Participant Satisfaction</measure>
    <time_frame>48 hours</time_frame>
    <description>Participants were asked whether or not they were satisfied with their postoperative pain control (yes or no)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Participant Satisfaction Score</measure>
    <time_frame>48 hours</time_frame>
    <description>Participants were asked to score their satisfaction with their postoperative pain control on a scale of 0 (least satisfied) to 10 (most satisfied)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Mitral Valve Insufficiency</condition>
  <arm_group>
    <arm_group_label>Paravertebral block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient receiving a PVB prior to robotic mitral valve surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No block</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients who did not receive PVB</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Paravertebral Block</intervention_name>
    <description>Paravertebral nerve block injection</description>
    <arm_group_label>Paravertebral block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo Comparator</intervention_name>
    <description>No block
Patients who did not receive PVB</description>
    <arm_group_label>No block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients over the age of 18 years of age undergoing robotic mitral valve surgery.

          -  have capacity to understand and sign consent form

        Exclusion Criteria:

          -  patients that are not candidates for paravertebral block as per ASRA guidelines
             (Horlocker, Reg Anesth Pain Med, 2010). In short, this includes patients taking
             specific anti platelet agents such as clopidigrel, anticoagulants such as heparin or
             low molecular weight heparin, or patients with an INR of greater than 1.5. -patients
             with a history of COPD or other respiratory diseases that would confound data on time
             to extubated will be excluded.

          -  Patients that with a diagnosis of chronic pain, or patients currently taking narcotics
             are excluded, as this would confound data on postoperative narcotic requirements.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter J Neuburger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NYU</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>NYU Langone Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Suri RM, Antiel RM, Burkhart HM, Huebner M, Li Z, Eton DT, Topilsky T, Sarano ME, Schaff HV. Quality of life after early mitral valve repair using conventional and robotic approaches. Ann Thorac Surg. 2012 Mar;93(3):761-9. doi: 10.1016/j.athoracsur.2011.11.062.</citation>
    <PMID>22364970</PMID>
  </reference>
  <reference>
    <citation>Lynch JJ, Mauermann WJ, Pulido JN, Rehfeldt KH, Torres NE. Use of paravertebral blockade to facilitate early extubation after minimally invasive cardiac surgery. Semin Cardiothorac Vasc Anesth. 2010 Mar;14(1):47-8. doi: 10.1177/1089253210363009.</citation>
    <PMID>20472625</PMID>
  </reference>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 1, 2014</study_first_submitted>
  <study_first_submitted_qc>July 2, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 3, 2014</study_first_posted>
  <results_first_submitted>February 16, 2016</results_first_submitted>
  <results_first_submitted_qc>February 16, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 15, 2016</results_first_posted>
  <last_update_submitted>February 16, 2016</last_update_submitted>
  <last_update_submitted_qc>February 16, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitral Valve Insufficiency</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Paravertebral Block</title>
          <description>Patient receiving a PVB prior to robotic mitral valce surgery
Paravertebral Block: Paravertebral nerve block injection</description>
        </group>
        <group group_id="P2">
          <title>No Block</title>
          <description>Patients who did not receive PVB
Placebo Comparator: No block
Patients who did not receive PVB</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Paravertebral Block</title>
          <description>Patient receiving a PVB prior to robotic mitral valce surgery
Paravertebral Block: Paravertebral nerve block injection</description>
        </group>
        <group group_id="B2">
          <title>No Block</title>
          <description>Patients who did not receive PVB
Placebo Comparator: No block
Patients who did not receive PVB</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="30"/>
            <count group_id="B2" value="30"/>
            <count group_id="B3" value="60"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60.1" spread="12.2"/>
                    <measurement group_id="B2" value="62.2" spread="11.9"/>
                    <measurement group_id="B3" value="61.15" spread="12.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Postoperative Fentanyl</title>
        <time_frame>24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Paravertebral Block</title>
            <description>Patient receiving a PVB prior to robotic mitral valve surgery
Paravertebral Block: Paravertebral nerve block injection</description>
          </group>
          <group group_id="O2">
            <title>No Block</title>
            <description>Patients who did not receive PVB
Placebo Comparator: No block
Patients who did not receive PVB</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Fentanyl</title>
          <units>microgram/kilogram</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.51" spread="2.5"/>
                    <measurement group_id="O2" value="6.14" spread="2.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Visual Analog Scale (VAS) Pain Scores</title>
        <description>Possible scores range from 0-10, with 0 being no pain and 10 being highest level of pain</description>
        <time_frame>24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Paravertebral Block</title>
            <description>Patient receiving a PVB prior to robotic mitral valve surgery
Paravertebral Block: Paravertebral nerve block injection</description>
          </group>
          <group group_id="O2">
            <title>No Block</title>
            <description>Patients who did not receive PVB
Placebo Comparator: No block
Patients who did not receive PVB</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Analog Scale (VAS) Pain Scores</title>
          <description>Possible scores range from 0-10, with 0 being no pain and 10 being highest level of pain</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.33" spread="1.52"/>
                    <measurement group_id="O2" value="4.13" spread="1.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Participant Satisfaction</title>
        <description>Participants were asked whether or not they were satisfied with their postoperative pain control (yes or no)</description>
        <time_frame>48 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Paravertebral Block</title>
            <description>Patient receiving a PVB prior to robotic mitral valve surgery
Paravertebral Block: Paravertebral nerve block injection</description>
          </group>
          <group group_id="O2">
            <title>No Block</title>
            <description>Patients who did not receive PVB
Placebo Comparator: No block
Patients who did not receive PVB</description>
          </group>
        </group_list>
        <measure>
          <title>Participant Satisfaction</title>
          <description>Participants were asked whether or not they were satisfied with their postoperative pain control (yes or no)</description>
          <units>percentage of &quot;yes&quot; responders</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100"/>
                    <measurement group_id="O2" value="86.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Participant Satisfaction Score</title>
        <description>Participants were asked to score their satisfaction with their postoperative pain control on a scale of 0 (least satisfied) to 10 (most satisfied)</description>
        <time_frame>48 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Paravertebral Block</title>
            <description>Patient receiving a PVB prior to robotic mitral valve surgery
Paravertebral Block: Paravertebral nerve block injection</description>
          </group>
          <group group_id="O2">
            <title>No Block</title>
            <description>Patients who did not receive PVB
Placebo Comparator: No block
Patients who did not receive PVB</description>
          </group>
        </group_list>
        <measure>
          <title>Participant Satisfaction Score</title>
          <description>Participants were asked to score their satisfaction with their postoperative pain control on a scale of 0 (least satisfied) to 10 (most satisfied)</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.44" spread="1.25"/>
                    <measurement group_id="O2" value="6.83" spread="1.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Paravertebral Block</title>
          <description>Patient receiving a PVB prior to robotic mitral valce surgery
Paravertebral Block: Paravertebral nerve block injection</description>
        </group>
        <group group_id="E2">
          <title>No Block</title>
          <description>Patients who did not receive PVB
Placebo Comparator: No block
Patients who did not receive PVB</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Peter Neuberger</name_or_title>
      <organization>NYU Langone Medical Center</organization>
      <phone>212 263 5821</phone>
      <email>Peter.Neuburger@nyumc.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

